NEW YORK (GenomeWeb News) – Enzo Biochem's Enzo Clinical Labs division will market Ikonisys' OncoFISH cervical test, under an agreement announced today.
Enzo Clinical Labs will have exclusive marketing rights for the test in New York and New Jersey. It will offer the assay to doctors requesting advanced analysis of specimens from liquid-based Pap tests to assist them in evaluating cytologic reports. Ikonisys will conduct the evaluation of the specimen using its own CellOptics platform on the Ikoniscope Digital Microscopy System for interpreting molecular signals.